News & Updates

Treatment with odevixibat led to rapid and sustained improvements in pruritus and serum bile acid (sBA) levels among patients with Alagille syndrome (ALGS), according to the final data of the phase III ASSERT-extension (ASSERT-EXT) study presented at The Liver Meeting 2024.

At a recent Pfizer-sponsored webinar, Dr Paula Ramirez Galleymore, an Intensive Care Medicine specialist from La Fe University and Polytechnic Hospital in Valencia, Spain, addressed the pressing issue of invasive candidiasis in the ICU — often an overlooked but frequent intruder in critical care settings. Galleymore discussed key aspects, including the primary risk factors associated with invasive Candida infections, emphasizing the need for early intervention to improve patient outcomes. She also explored antifungal treatment options, focusing on the clinical efficacy and guideline recommendations for echinocandins.

Endoscopists may unintentionally play down the risks of antiplatelet-related postendoscopic retrograde cholangiopancreatography (ERCP) bleeding (CSPEB) based on observations of suboptimal holding before higher risk ERCP, reports a study.

Administering hyperthermic intraperitoneal chemotherapy (HIPEC) during cytoreductive surgery for recurrent ovarian cancer helps prolong overall survival, according to the results of the phase III open-label CHIPOR trial.